Browsing by Author "Yesilaltay, A"

Now showing 1 - 2 of 2
  • Thumbnail Image
    Item
    Effects of hepatic expression of the high-density lipoprotein receptor SR-BI on lipoprotein metabolism and female fertility
    (ENDOCRINE SOC, 2006) Yesilaltay, A; Morales, MG; Amigo, L; Zanlungo, S; Rigotti, A; Karackattu, SL; Donahee, MH; Kozarsky, KF; Krieger, M
    The etiology of human female infertility is often uncertain. The sterility of high-density lipoprotein (HDL) receptor-negative (SR-BI-/-) female mice suggests a link between female infertility and abnormal lipoprotein metabolism. SR-BI-/- mice exhibit elevated plasma total cholesterol [ with normalsized and abnormally large HDL and high unesterified to total plasma cholesterol (UC:TC) ratio]. We explored the influence of hepatic SR-BI on female fertility by inducing hepatic SR-BI expression in SR-BI-/- animals by adenovirus transduction or stable transgenesis. For transgenes, we used both wild-type SR-BI and a double-point mutant, Q402R/Q418R (SR-BI-RR), which is unable to bind to and mediate lipid transfer from wild-type HDL normally, but retains virtually normal lipid transport activities with low-density lipoprotein. Essentially wild-type levels of hepatic SR-BI expression in SR-BI-/- mice restored to nearly normal the HDL size distribution and plasma UC: TC ratio, whereas approximately 7- to 40- fold overexpression dramatically lowered plasma TC and increased biliary cholesterol secretion. In contrast, SR-BI-RR overexpression had little effect on SR-BI-/- mice, but in SR-BI-/- mice, it substantially reduced levels of abnormally large HDL and normalized the UC: TC ratio. In all cases, hepatic transgenic expression restored female fertility. Overexpression in SR-BI-/- mice of lecithin: cholesterol acyl transferase, which esterifies plasma HDL cholesterol, did not normalize the UC: TC ratio, probably because the abnormal HDL was a poor substrate, and did not restore fertility. Thus, hepatic SR- BImediated lipoprotein metabolism influences murine female fertility, raising the possibility that dyslipidemia might contribute to human female infertility and that targeting lipoprotein metabolism might complement current assisted reproductive technologies.
  • Thumbnail Image
    Item
    Targeted disruption of the PDZK1 gene in mice causes tissue-specific depletion of the high density lipoprotein receptor scavenger receptor class B type I and altered lipoprotein metabolism
    (AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC, 2003) Kocher, O; Yesilaltay, A; Cirovic, C; Pal, R; Rigotti, A; Krieger, M
    PDZK1, a multi-PDZ domain containing adaptor protein, interacts with various membrane proteins, including the high density lipoprotein (HDL) receptor scavenger receptor class B type I (SR-BI). Here we show that PDZK1 controls in a tissue-specific and post-transcriptional fashion the expression of SR-BI in vivo. SR-BI protein expression in PDZK1 knock-out (KO) mice was reduced by 95% in the liver, 50% in the proximal intestine, and not affected in steroidogenic organs (adrenal, ovary, and testis). Thus, PDZK1 joins a growing list of adaptors that control tissue-specific activity of cell surface receptors. Hepatic expression of SR-BII, a minor splice variant with an alternative C-terminal cytoplasmic domain, was not affected in PDZK1 KO mice, suggesting that binding of PDZK1 to SR-BI is required for controlling hepatic SR-BI expression. The loss of hepatic SR-BI was the likely cause of the elevation in plasma total and HDL cholesterol and the increase in HDL particle size in PDZK1 KO mice, phenotypes similar to those observed in SR-BI KO mice. PDZK1 KO mice differed from SR-BI KO mice in that the ratio of unesterified to total plasma cholesterol was normal, females were fertile, and cholesteryl ester stores in steroidogenic organs were essentially unaffected. These differences may be due to nearly normal extrahepatic expression of SR-BI in PDZK1 KO mice. The PDZK1-dependent regulation of hepatic SR-BI and, thus, lipoprotein metabolism supports the proposal that this adaptor may represent a new target for therapeutic intervention in cardiovascular disease.